Suppr超能文献

TGF-β 上调 miR-181a 的表达以促进乳腺癌转移。

TGF-β upregulates miR-181a expression to promote breast cancer metastasis.

机构信息

Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio 44106, USA.

出版信息

J Clin Invest. 2013 Jan;123(1):150-63. doi: 10.1172/JCI64946. Epub 2012 Dec 17.

Abstract

Late-stage breast cancer metastasis is driven by dysregulated TGF-β signaling, but the underlying molecular mechanisms have not been fully elucidated. We attempted to recapitulate tumor and metastatic microenvironments via the use of biomechanically compliant or rigid 3D organotypic cultures and combined them with global microRNA (miR) profiling analyses to identify miRs that were upregulated in metastatic breast cancer cells by TGF-β. Here we establish miR-181a as a TGF-β-regulated "metastamir" that enhanced the metastatic potential of breast cancers by promoting epithelial-mesenchymal transition, migratory, and invasive phenotypes. Mechanistically, inactivation of miR-181a elevated the expression of the proapoptotic molecule Bim, which sensitized metastatic cells to anoikis. Along these lines, miR-181a expression was essential in driving pulmonary micrometastatic outgrowth and enhancing the lethality of late-stage mammary tumors in mice. Finally, miR-181a expression was dramatically and selectively upregulated in metastatic breast tumors, particularly triple-negative breast cancers, and was highly predictive for decreased overall survival in human breast cancer patients. Collectively, our findings strongly implicate miR-181a as a predictive biomarker for breast cancer metastasis and patient survival, and consequently, as a potential therapeutic target in metastatic breast cancer.

摘要

晚期乳腺癌转移是由失调的 TGF-β 信号驱动的,但潜在的分子机制尚未完全阐明。我们试图通过使用生物力学顺应性或刚性 3D 器官型培养物来再现肿瘤和转移微环境,并将其与全局 microRNA (miR) 谱分析相结合,以鉴定出 TGF-β 上调的转移性乳腺癌细胞中的 miR。在这里,我们确定 miR-181a 是一种 TGF-β 调节的“转移 mir”,通过促进上皮-间充质转化、迁移和侵袭表型来增强乳腺癌的转移潜力。在机制上,miR-181a 的失活会提高促凋亡分子 Bim 的表达,从而使转移性细胞对无附著生存敏感。沿著这些思路,miR-181a 的表达对于驱动肺微转移的生长和增强小鼠晚期乳腺肿瘤的致死性至关重要。最后,miR-181a 的表达在转移性乳腺癌中显著且选择性地上调,特别是在三阴性乳腺癌中,并且对人类乳腺癌患者的总体生存率具有高度预测性。总的来说,我们的研究结果强烈暗示 miR-181a 作为乳腺癌转移和患者生存的预测性生物标志物,以及转移性乳腺癌的潜在治疗靶点。

相似文献

1
TGF-β upregulates miR-181a expression to promote breast cancer metastasis.
J Clin Invest. 2013 Jan;123(1):150-63. doi: 10.1172/JCI64946. Epub 2012 Dec 17.
8
MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.
J Clin Invest. 2013 Feb;123(2):566-79. doi: 10.1172/JCI65871. Epub 2013 Jan 16.
9
MiR-181b promotes chemoresistance in breast cancer by regulating Bim expression.
Oncol Rep. 2016 Feb;35(2):683-90. doi: 10.3892/or.2015.4417. Epub 2015 Nov 13.

引用本文的文献

1
3
Extracellular vesicles and miRNA-based therapies in triple-negative breast cancer: advances and clinical perspectives.
Extracell Vesicles Circ Nucl Acids. 2025 Feb 14;6(1):54-71. doi: 10.20517/evcna.2024.85. eCollection 2025.
5
Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.
Int J Mol Sci. 2024 Dec 26;26(1):127. doi: 10.3390/ijms26010127.
6
hsa-mir-483-3p modulates delayed breast cancer recurrence.
Sci Rep. 2025 Jan 3;15(1):693. doi: 10.1038/s41598-024-84437-6.
7
: regulatory roles, cancer-associated signaling pathway disruptions, and therapeutic potential.
Expert Opin Ther Targets. 2024 Dec;28(12):1061-1091. doi: 10.1080/14728222.2024.2433687. Epub 2024 Dec 8.
8
Modulation of miR-205 expression using a phyto-nano hybrid as a potential therapeutic agent against breast cancer.
RSC Adv. 2024 Nov 21;14(50):37286-37298. doi: 10.1039/d4ra03069a. eCollection 2024 Nov 19.
9
Shedding Light on the Molecular Diversities of miRNA in Cancer- an Exquisite Mini Review.
Mol Biotechnol. 2024 Nov 4. doi: 10.1007/s12033-024-01312-5.
10
Advancements in precision nanomedicine design targeting the anoikis-platelet interface of circulating tumor cells.
Acta Pharm Sin B. 2024 Aug;14(8):3457-3475. doi: 10.1016/j.apsb.2024.04.034. Epub 2024 May 8.

本文引用的文献

1
miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients.
Biochem Biophys Res Commun. 2012 Apr 27;421(1):4-8. doi: 10.1016/j.bbrc.2012.03.025. Epub 2012 Mar 13.
2
MicroRNA-181a - a tale of discrepancies.
Expert Rev Mol Med. 2012 Feb 21;14:e5. doi: 10.1017/S1462399411002122.
3
Smad-mediated regulation of microRNA biosynthesis.
FEBS Lett. 2012 Jul 4;586(14):1906-12. doi: 10.1016/j.febslet.2012.01.041. Epub 2012 Jan 28.
4
miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2.
Acta Biochim Biophys Sin (Shanghai). 2012 Mar;44(3):269-77. doi: 10.1093/abbs/gmr128. Epub 2012 Jan 26.
5
Matrix rigidity regulates a switch between TGF-β1-induced apoptosis and epithelial-mesenchymal transition.
Mol Biol Cell. 2012 Mar;23(5):781-91. doi: 10.1091/mbc.E11-06-0537. Epub 2012 Jan 11.
6
Cancer statistics, 2012.
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
7
BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors.
Cancer Discov. 2011 Sep;1(4):352-65. doi: 10.1158/2159-8290.CD-11-0106. Epub 2011 Jul 22.
8
KEGG for integration and interpretation of large-scale molecular data sets.
Nucleic Acids Res. 2012 Jan;40(Database issue):D109-14. doi: 10.1093/nar/gkr988. Epub 2011 Nov 10.
9
Tumor metastasis: molecular insights and evolving paradigms.
Cell. 2011 Oct 14;147(2):275-92. doi: 10.1016/j.cell.2011.09.024.
10
miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes.
Mitochondrion. 2012 Mar;12(2):213-9. doi: 10.1016/j.mito.2011.09.001. Epub 2011 Sep 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验